NRC Health
NRC- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0000070487
No open-market purchases or sales by NRC Health insiders were filed in the last 90 days; 123 institutions reported holding it in 13F filings for Q2 2026, worth $231.9M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in NRC Health as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- +2 vs. Q1 2021
- Shares held
- 11.2M
- +271.6K (+2.5%) vs. Q1 2021
- Total value
- $514.2M
- +$2.91M (+0.6%) vs. Q1 2021
- New holders
- 13
- 28 more added
- Sold out
- 11
- 35 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 123 | $231.9M |
| Q1 2026 | 121 | $184.2M |
| Q4 2025 | 117 | $201.6M |
| Q3 2025 | 119 | $142.0M |
| Q2 2025 | 126 | $196.1M |
| Q1 2025 | 123 | $147.3M |
| Q4 2024 | 133 | $209.6M |
| Q3 2024 | 138 | $273.5M |
| Q2 2024 | 136 | $280.3M |
| Q1 2024 | 142 | $505.2M |
| Q4 2023 | 132 | $476.7M |
| Q3 2023 | 121 | $538.4M |
| Q2 2023 | 116 | $507.8M |
| Q1 2023 | 125 | $498.7M |
| Q4 2022 | 116 | $437.3M |
| Q3 2022 | 111 | $464.7M |
| Q2 2022 | 110 | $441.0M |
| Q1 2022 | 116 | $456.3M |
| Q4 2021 | 113 | $473.7M |
| Q3 2021 | 109 | $473.7M |
| Q2 2021 | 101 | $514.2M |
| Q1 2021 | 99 | $511.3M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding NRC Health; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kayne Anderson Rudnick Investment Management LLC | 3,330,144 | $152.9M | 0.38% | −68,295−2.0% | Reduced |
| Bahl & Gaynor Inc | 0 | $0 | 0.00% | −44,168−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −8,908−100.0% | Sold out |
| Klingman & Associates, LLC | 0 | $0 | 0.00% | −7,000−100.0% | Sold out |
| Legacy Wealth Asset Management, LLC | 0 | $0 | 0.00% | −4,931−100.0% | Sold out |
| Zebra Capital Management LLC | 0 | $0 | 0.00% | −4,449−100.0% | Sold out |
| FIL Ltd | 0 | $0 | 0.00% | −450−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −426−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |